STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8
Clinical trials for STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat uterine cancer: trial tests multiple drug combos
Disease control OngoingThis study is testing several drug combinations to see which works best for women with advanced endometrial cancer that has returned or stopped responding to treatment. It compares single drugs against combinations to see which can better control the cancer and keep it from growi…
Matched conditions: STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major trial tests new weapon against advanced uterine cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called pembrolizumab to standard chemotherapy works better for treating advanced or recurrent endometrial cancer. It involves over 800 patients with stage III, IV, or returning cancer. The goal is to see…
Matched conditions: STAGE IV UTERINE CORPUS CARCINOMA OR CARCINOSARCOMA AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC